CA1067078A - Pharmacologically active substituted phenyl hydrazino-pyridazines - Google Patents

Pharmacologically active substituted phenyl hydrazino-pyridazines

Info

Publication number
CA1067078A
CA1067078A CA229,160A CA229160A CA1067078A CA 1067078 A CA1067078 A CA 1067078A CA 229160 A CA229160 A CA 229160A CA 1067078 A CA1067078 A CA 1067078A
Authority
CA
Canada
Prior art keywords
butylamino
hydroxypropoxy
give
mole
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA229,160A
Other languages
English (en)
French (fr)
Other versions
CA229160S (en
Inventor
William J. Coates
Anthony M. Roe
Robert A. Slater
Edwin M. Taylor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB26864/74A external-priority patent/GB1527712A/en
Application filed by Smith Kline and French Laboratories Ltd filed Critical Smith Kline and French Laboratories Ltd
Application granted granted Critical
Publication of CA1067078A publication Critical patent/CA1067078A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/56—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups bound to carbon atoms of six-membered aromatic rings and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/32—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups
    • C07C65/40—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups containing singly bound oxygen-containing groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/12—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/18—Sulfur atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CA229,160A 1974-06-18 1975-06-12 Pharmacologically active substituted phenyl hydrazino-pyridazines Expired CA1067078A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB26864/74A GB1527712A (en) 1974-06-18 1974-06-18 Hydrazinopyridazines
GB2075 1975-01-02

Publications (1)

Publication Number Publication Date
CA1067078A true CA1067078A (en) 1979-11-27

Family

ID=26235616

Family Applications (1)

Application Number Title Priority Date Filing Date
CA229,160A Expired CA1067078A (en) 1974-06-18 1975-06-12 Pharmacologically active substituted phenyl hydrazino-pyridazines

Country Status (15)

Country Link
US (1) US4053601A (en, 2012)
JP (1) JPS5113782A (en, 2012)
CA (1) CA1067078A (en, 2012)
CH (1) CH617429A5 (en, 2012)
DE (1) DE2527066A1 (en, 2012)
DK (1) DK145099C (en, 2012)
ES (1) ES438685A1 (en, 2012)
FI (1) FI62532C (en, 2012)
FR (1) FR2275213A1 (en, 2012)
IE (1) IE42214B1 (en, 2012)
IL (1) IL47351A (en, 2012)
LU (1) LU72739A1 (en, 2012)
NL (1) NL7507267A (en, 2012)
SE (1) SE416650B (en, 2012)
SU (1) SU862824A3 (en, 2012)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4314943A (en) * 1977-07-13 1982-02-09 Mead Johnson & Company Heterocyclic substituted aryloxy 3-indolyl-tertiary butylaminopropanols
US4272440A (en) * 1978-02-24 1981-06-09 Smithkline Corporation Intermediates for preparing hydroxyphenylpyridazinones
IN148775B (en, 2012) * 1978-08-04 1981-06-13 Smithkline & French Lab Ltd Uk
US4495352A (en) * 1979-02-13 1985-01-22 Mead Johnson & Company Heterocyclic substituted aryloxy 3-indolyl-tertiary butylaminopropanols
DE3028453A1 (de) * 1980-07-26 1982-03-18 Zinser Textilmaschinen Gmbh, 7333 Ebersbach Spinnmaschine
US4340733A (en) * 1980-09-02 1982-07-20 Smithkline Corporation Process for preparing 3-chloro-6-(2-hydroxyphenyl)-pyridazines
EP0101156A3 (en) * 1982-06-24 1984-08-22 Smith Kline & French Laboratories Limited Process for preparing 6-(2-hydroxyphenyl)-3-pyridazinone
DE3302442A1 (de) * 1983-01-26 1984-07-26 Basf Ag, 6700 Ludwigshafen Neue pyridazinone, verfahren zu ihrer herstellung, diese verbindungen enthaltende therapeutische mittel und deren verwendung
GB8323553D0 (en) * 1983-09-02 1983-10-05 Smith Kline French Lab Pharmaceutical compositions
JPH0629254B2 (ja) * 1986-09-08 1994-04-20 帝国臓器製薬株式会社 ピリダジノン誘導体
IL159320A0 (en) 2001-06-12 2004-06-01 Wellstat Therapeutics Corp Compounds for the treatment of metabolic disorders
CA2658821C (en) * 2006-07-25 2014-10-21 Cephalon, Inc. Pyridizinone derivatives and uses thereof to treat diseases, disorders and/or conditions that may be mediated or modulated by inhibition of h3 receptors
WO2013106547A1 (en) 2012-01-10 2013-07-18 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use
TW202216671A (zh) * 2020-06-25 2022-05-01 瑞士商諾華公司 １，４—二取代的嗒𠯤化合物之製造方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE758146A (fr) * 1969-10-29 1971-04-28 Smith Kline French Lab Derives de l'amidine
US3818097A (en) * 1969-10-29 1974-06-18 Smith Kline French Lab Method of inhibiting histamine activity with isothioureas
IT1054107B (it) * 1970-12-15 1981-11-10 Isf Spa Nuove 3,idrazinopiridazine 6,sostituite ad attivita antiiperten siva e loro preparazione
US3975530A (en) * 1972-09-05 1976-08-17 Smith Kline & French Laboratories Limited N-cyano-N'-heterocyclic-alkyl quanidine inhibitors of H2 histamine receptors

Also Published As

Publication number Publication date
AU8158175A (en) 1976-12-02
FI62532C (fi) 1983-01-10
FR2275213A1 (fr) 1976-01-16
IL47351A0 (en) 1975-07-28
FR2275213B1 (en, 2012) 1979-08-10
DK145099C (da) 1983-01-31
FI751790A7 (en, 2012) 1975-12-19
DK245275A (da) 1975-12-19
NL7507267A (nl) 1975-12-22
ES438685A1 (es) 1977-05-16
IL47351A (en) 1980-02-29
LU72739A1 (en, 2012) 1975-10-08
JPS5113782A (en, 2012) 1976-02-03
DE2527066A1 (de) 1976-01-08
FI62532B (fi) 1982-09-30
IE42214L (en) 1975-12-18
US4053601A (en) 1977-10-11
CH617429A5 (en, 2012) 1980-05-30
SU862824A3 (ru) 1981-09-07
IE42214B1 (en) 1980-07-02
SE7506947L (sv) 1975-12-19
SE416650B (sv) 1981-01-26
DK145099B (da) 1982-08-30

Similar Documents

Publication Publication Date Title
CA1067078A (en) Pharmacologically active substituted phenyl hydrazino-pyridazines
US3931177A (en) 6-(3-Substituted amino-2-hydroxypropoxyaryl)-4,5-dihydro-3(2H)-pyridazinones
US4011321A (en) Pharmaceutical compositions and methods of inhibiting β-adrenergic receptors
CA1245651A (en) Pyridazinones, preparation process thereof and utilization thereof, drugs containing pyridazinones
EP0275997B1 (en) 3(2h)pyridazinone, process for its preparation and antagonistic agent against srs-a containing it
IE46852B1 (en) Novel carbostyril derivatives
CA2335104C (en) Arylalkanoylpyridazines
US3975388A (en) Pyridazinones
US4670434A (en) (2-oxo-3-methylene-1,2,3,5-tetrahydroimidazo[2,1-b]quinazolinyl)oxyalkylamides useful as cyclic AMP phosphodiesterase inhibitors
US6680316B1 (en) Pyridazin-3-one derivatives and medicines containing the same
HU203748B (en) Process for producing new piperazinyl-alkyl-amino-3(2h)-pyridazinone derivatives and pharmaceutical compositions containing them
US5942511A (en) Allylthiopyridazine derivatives and process for preparing the same
EP0201765B1 (en) 3(2h)pyridazinone, process for its preparation and anti-allergic agent containing it
EP0006407B1 (en) Hydantoin derivatives, their preparation and pharmaceutical compositions containing them
US4082843A (en) 3-(3-(3-Substituted amino-2-hydroxypropoxy)phenyl)-6-hydrazino pyridazines and their use as vasodilators and β-adrenergic blocking agents
US4088762A (en) 6-(P-PIPERAZINO)-PHENYL-4,5-DIHYDRO-3(2H)pyridazinones
IE45696B1 (en) Derivatives of 2-(3-phenyl-2-aminopropionyloxy)-acetic acid
US4007276A (en) Triazolo isoindole derivatives
US4111936A (en) Pyridazinethiones
JPS6159626B2 (en, 2012)
US4111935A (en) 3-chloro-6-phenylpyridazine compounds
US4882337A (en) Tetrahydroisoquinoline antiarrhythmic agents
IE46730B1 (en) Pyridazinone derivatives
JP4472337B2 (ja) アルキルアミノピリダジノン誘導体、この調製方法、およびこれを含む医薬組成物
US4093725A (en) (3-Alkylamino-2-hydroxypropoxy)-1-hydrazinophthalazines